Literature DB >> 12604501

Outbreak of Stevens-Johnson syndrome/toxic epidermal necrolysis associated with mebendazole and metronidazole use among Filipino laborers in Taiwan.

Kow-Tong Chen1, Shiing-Jer Twu, Hong-Jen Chang, Ruey-Shiung Lin.   

Abstract

OBJECTIVES: This study sought to identify the risk factors associated with an outbreak of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) among Filipino laborers in Taiwan.
METHODS: Forty-six SJS/TEN patients were matched to 92 controls according to month of arrival in Taiwan, sex, and age.
RESULTS: The odds ratio for development of SJS/TEN was 9.5 (95% confidence interval [CI] = 3.9, 23.9) among workers who had used both metronidazole and mebendazole sometime in the preceding 6 weeks. In addition, a gradient increase in the occurrence of SJS/TEN was found with an increasing level of exposure to metronidazole.
CONCLUSIONS: This outbreak highlights the risk of SJS/TEN resulting from the use of both metronidazole and mebendazole and the need for control measures.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12604501      PMCID: PMC1447769          DOI: 10.2105/ajph.93.3.489

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  14 in total

1.  An unusual bullous eruption.

Authors:  R LANG; J WALKER
Journal:  S Afr Med J       Date:  1956-02-04

2.  Work-related toxic epidermal necrolysis?

Authors:  R A House; H Jakubovic; L Wong; D L Holness
Journal:  J Occup Med       Date:  1992-02

3.  Genetic susceptibility to toxic epidermal necrolysis.

Authors:  J C Roujeau; T N Huynh; C Bracq; J C Guillaume; J Revuz; R Touraine
Journal:  Arch Dermatol       Date:  1987-09

4.  Stevens-Johnson syndrome after mass prophylaxis with sulfadoxine for cholera in Mozambique.

Authors:  A Hernborg
Journal:  Lancet       Date:  1985-11-09       Impact factor: 79.321

Review 5.  Severe adverse cutaneous reactions to drugs.

Authors:  J C Roujeau; R S Stern
Journal:  N Engl J Med       Date:  1994-11-10       Impact factor: 91.245

6.  Validity of self-reports of alcohol and other drug use: a multitrait-multimethod assessment.

Authors:  A W Stacy; K F Widaman; R Hays; M R DiMatteo
Journal:  J Pers Soc Psychol       Date:  1985-07

7.  Etiologic factors of the Stevens-Johnson syndrome.

Authors:  J Z Yetiv; J R Bianchine; J A Owen
Journal:  South Med J       Date:  1980-05       Impact factor: 0.954

8.  Observations on drug-induced toxic epidermal necrolysis in Singapore.

Authors:  H L Chan
Journal:  J Am Acad Dermatol       Date:  1984-06       Impact factor: 11.527

9.  Erythema multiforme (Stevens-Johnson syndrome)--chart review of 123 hospitalized patients.

Authors:  J R Nethercott; B C Choi
Journal:  Dermatologica       Date:  1985

10.  Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.

Authors:  S Bastuji-Garin; B Rzany; R S Stern; N H Shear; L Naldi; J C Roujeau
Journal:  Arch Dermatol       Date:  1993-01
View more
  11 in total

1.  Two cases of Stevens-Johnson syndrome following intake of klavox with review of literature.

Authors:  Kamal-Eldin Ahmed Abou-Elhamd
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-08-13       Impact factor: 2.503

2.  Enterobiasis: threadworm infection presenting as acute appendicitis in a 13-year-old girl.

Authors:  Shohib Tariq
Journal:  BMJ Case Rep       Date:  2015-01-14

Review 3.  Occupational skin diseases in Korea.

Authors:  Yeon-Soon Ahn; Min-Gi Kim
Journal:  J Korean Med Sci       Date:  2010-12-15       Impact factor: 2.153

Review 4.  Endoscopic and non-endoscopic approaches for the management of radiation-induced rectal bleeding.

Authors:  Joseph Paul Weiner; Andrew Thomas Wong; David Schwartz; Manuel Martinez; Ayse Aytaman; David Schreiber
Journal:  World J Gastroenterol       Date:  2016-08-21       Impact factor: 5.742

5.  Outbreak of Mycoplasma pneumoniae-Associated Stevens-Johnson Syndrome.

Authors:  Daniel Olson; Louise K Francois Watkins; Alicia Demirjian; Xia Lin; Christine C Robinson; Kristin Pretty; Alvaro J Benitez; Jonas M Winchell; Maureen H Diaz; Lisa A Miller; Teresa A Foo; Melanie D Mason; Ursula L Lauper; Oren Kupfer; Jeffrey Kennedy; Mary P Glodé; Preeta K Kutty; Samuel R Dominguez
Journal:  Pediatrics       Date:  2015-08       Impact factor: 7.124

Review 6.  A review of pharmacokinetic drug-drug interactions with the anthelmintic medications albendazole and mebendazole.

Authors:  Shane Ashley Pawluk; Craig Allan Roels; Kyle John Wilby; Mary H H Ensom
Journal:  Clin Pharmacokinet       Date:  2015-04       Impact factor: 5.577

Review 7.  Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN): could retinoids play a causative role?

Authors:  Anthony R Mawson; Ike Eriator; Sridhar Karre
Journal:  Med Sci Monit       Date:  2015-01-12

8.  Mebendazole and temozolomide in patients with newly diagnosed high-grade gliomas: results of a phase 1 clinical trial.

Authors:  Gary L Gallia; Matthias Holdhoff; Henry Brem; Avadhut D Joshi; Christine L Hann; Ren-Yuan Bai; Verena Staedtke; Jaishri O Blakeley; Soma Sengupta; T Che Jarrell; Jessica Wollett; Kelly Szajna; Nicole Helie; Austin K Mattox; Xiaobu Ye; Michelle A Rudek; Gregory J Riggins
Journal:  Neurooncol Adv       Date:  2020-11-12

9.  Severe cutaneous adverse drug reactions manifesting as Stevens-Johnson syndrome and toxic epidermal necrolysis reported to the national pharmacovigilance center in Nigeria: a database review from 2004 to 2017.

Authors:  Kazeem Adeola Oshikoya; Ibrahim Abayomi Ogunyinka; Comfort Kunak Ogar; Abiodun Abiola; Ali Ibrahim; Ibrahim Adekunle Oreagba
Journal:  Ther Adv Drug Saf       Date:  2020-02-12

10.  Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update.

Authors:  Jong-Yil Chai; Bong-Kwang Jung; Sung-Jong Hong
Journal:  Korean J Parasitol       Date:  2021-06-21       Impact factor: 1.341

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.